| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,302 | 0,438 | 11:01 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 30.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 27.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 2 | ASX | ||
| ADVANCE ZINCTEK Aktie jetzt für 0€ handeln | |||||
| 23.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 22.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 20.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 15.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 14.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 08.10. | ADVANCE ZINCTEK LIMITED: First Quarter FY27 Australian Revenue Down 71% | - | ASX | ||
| 31.08. | Advance Zinctek Ltd Profit Advances In Full Year | 1 | RTTNews | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Corporate Governance Statement | 1 | ASX | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Appendix 4G | 1 | ASX | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Annual Report to shareholders | 1 | ASX | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Appendix 4E | 2 | ASX | ||
| 04.08. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 31.07. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 22.07. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 20.07. | Advance ZincTek (ASX:ANO) lifts pre-tax profit 13% as enquiry pipeline builds | 2 | Stocks Down Under | ||
| 20.07. | ADVANCE ZINCTEK LIMITED: FY26 Unaudited Profit Before Tax Up 13% on Prior Year | - | ASX | ||
| 01.07. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 13,920 | -1,14 % | Formycon Aktie: Keytruda-Nachahmer könnte zum Milliarden-Türöffner werden | Für Formycon rückt mit dem Biosimilar-Kandidaten FYB206 der wichtigste Werttreiber des Unternehmens näher an eine mögliche Markteinführung. Die US-Arzneimittelbehörde FDA hat den Zulassungsantrag für... ► Artikel lesen | |
| VEECO INSTRUMENTS | 31,100 | 0,00 % | Axcelis Technologies and Veeco Instruments Provide Update on Expected Timing of Merger Closing | Merger now expected to close by the end of the first quarter of 2027 BEVERLY, Mass., and PLAINVIEW, N.Y., Nov. 2, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") and Veeco... ► Artikel lesen | |
| ONTO INNOVATION | 156,00 | +0,35 % | Onto Innovation: Diese KI-Aktie ist ein Favorit für 2027 | Die Aktie von Onto Innovation ist im Zuge der jüngsten Gewinnmitnahmen bei Halbleiterwerten deutlich unter Druck geraten. Angesichts starker Geschäftszahlen und wachsender Nachfrage durch den KI-Boom... ► Artikel lesen | |
| RIBER | 5,740 | 0,00 % | Riber Reports Improved Results For The First Half Of 2026 | RIBER REPORTS IMPROVED RESULTS FOR THE FIRST HALF OF 2026 Revenues of €12.7m (+19%) and gross margin of €5.1m (+31%), representing 39.8% of revenuesPositive net income of €0.2m, compared with -€0.8m... ► Artikel lesen | |
| LAMPETIA | 0,124 | +6,90 % | EQS-Adhoc: Lampetia AG: Verkauf der Lampetia Investments Engineering Ltd geplant | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Mergers und Acquisitions / Verkauf von Unternehmensteilen
Lampetia AG: Verkauf der Lampetia Investments Engineering Ltd geplant
06.11.2026... ► Artikel lesen | |
| KOPIN | 2,607 | -4,30 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| GAUZY | 5,950 | -3,25 % | Research Frontiers expects material royalty recovery after Q4 2026 as Gauzy restarts SPD production | ||
| GOMSPACE | 1,055 | +1,05 % | GomSpace Group AB: GomSpace reports continued profitable growth in Q3 and narrows full year guidance | GomSpace reports continued profitable growth in Q3 and narrows full year guidance
GomSpace delivers revenue growth with a 14% EBITDA margin in Q3 and sets 2030 financial targets of SEK 1.6 billion... ► Artikel lesen | |
| OBDUCAT | 0,030 | 0,00 % | NGM MARKET NOTICE: #26-72 Decision by the Disciplinary Committee regarding Obducat AB (publ) | ||
| SOLESENCE | 0,850 | -0,83 % | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| ZENTEK | 0,330 | -1,20 % | Zentek Ltd.: Zentek Provides Corporate Update on Nasdaq Listing | Guelph, Ontario--(Newsfile Corp. - October 26, 2026) - Zentek Ltd. (TSXV: ZEN) (OTCQX: ZTEKF) ("Zentek" or the "Company") today provides an update on the Nasdaq appeal process it began after The Nasdaq... ► Artikel lesen | |
| ACACIA RESEARCH | 3,740 | +5,06 % | ACACIA RESEARCH CORP - 10-K/A, Annual Report | ||
| NVE | 62,00 | 0,00 % | Dividendenbekanntmachungen (02.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABM INDUSTRIES INC US0009571003 0,29 USD EUR ACUITY INC US00508Y1029 0,2 USD EUR AMERISERV FINANCIAL INC US03074A1025 0,03... ► Artikel lesen | |
| DOTZ NANO | 0,007 | +121,21 % | DOTZ Nano signs five-year ChillerAI agreement in Israel | ||
| NANOVIRICIDES | 1,160 | +2,65 % | As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides | SHELTON, CT / ACCESS Newswire / October 27, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, explained... ► Artikel lesen |